|
|
| Research article summary (published 13 Apr 2002): |
|
Free Full Text! See links below |
Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.
Full Abstract
A reduced risk for Parkinson's disease (PD) among cigarette smokers has been observed consistently during the past 30 years. Recent evidence suggests that caffeine may also be protective. Findings are presented regarding associations of PD with smoking, caffeine intake, and alcohol consumption from a case-control study conducted in western Washington State in 1992-2000. Incident PD cases (n = 210) and controls (n = 347), frequency matched on gender and age were identified from enrollees of the Group Health Cooperative health maintenance organization. Exposure data were obtained by in-person questionnaires. Ever having smoked cigarettes was associated with a reduced risk of PD (odds ratio (OR) = 0.5, 95% confidence interval (CI): 0.4, 0.8). A stronger relation was found among current smokers (OR = 0.3, 95% CI: 0.1, 0.7) than among ex-smokers (OR = 0.6, 95% CI: 0.4, 0.9), and there was an inverse gradient with pack-years smoked (trend p < 0.001). No associations were detected for coffee consumption or total caffeine intake or for alcohol consumption. However, reduced risks were observed for consumption of 2 cups/day or more of tea (OR = 0.4, 95% CI: 0.2, 0.9) and two or more cola drinks/day (OR = 0.6, 95% CI: 0.3, 1.4). The associations for tea and cola drinks were not confounded by smoking or coffee consumption.
Author information
Author/s: Checkoway, Harvey (H); Powers, Karen (K); Smith-Weller, Terri (T); Franklin, Gary M (GM); Longstreth, W T (WT); Swanson, Phillip D (PD);
Affiliation: University of Washington, School of Public Health and Community Medicine, Department of Environmental Health, Seattle, WA 98195, USA. checko(-atsign-)u.washington.edu
Grants: ES04696 (Agency:NIEHS NIH HHS) ; ES10750 (Agency:NIEHS NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal: American journal of epidemiology (Am J Epidemiol), published in United States. (Language: eng)
Reference: 2002-Apr; vol 155 (issue 8) : pp 732-8
Dates: Created 2002/04/10; Completed 2002/04/24; Revised 2007/11/15;
PMID: 11943691, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Viagra and broken hearts.
30 Jan 2000 - Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers.
30 Aug 2004 - Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
30 Oct 2006 - Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
29 Jun 1990 - Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study.
30 Mar 1997 - Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
30 Jul 2000 - [Parkinsonism or Parkinson's disease unmasked by pentoxifylline?]
30 Dec 2000 - Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer.
29 Sep 2002 - Evaluation of the efficacy of a combined formulation (Grippostad-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trial.
27 Feb 2003
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.